4.35 (0.26%) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that the Company will attend ‘Incred Equities Virtual Conference’ on 14-March-2023 to meet Analyst/Institutional virtually.
The above information is a part of company’s filings submitted to BSE.